H

Hospital Nacional Dos de Mayo | Medicina Interna Department

Research site

(Unclaimed)

Location

Avenida Miguel Grau 13 Parque Historia de la Medicina Peruana, Lima, Lima, Peru

Site insights

Top conditions

Top treatments

Ocrelizumab

Pregabalin

Linagliptin

Interferon

CS-7017

Crovalimab

Rifampicin

Pegcetacoplan

Glimepiride

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 13 total trials

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) (COMMUTE-a)

This study aims to evaluate the efficacy and safety of crovalimab in adult and adolescent participants with aHUS.

Active, not recruiting

Atypical Hemolytic Uremic Syndrome

Drug: Crovalimab

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS) (GAVOTTE)

This is a randomized, double blind, controlled, parallel group, multicenter study to evaluate efficacy, safety and PK of a higher dose of ocrelizumab...

Active, not recruiting

Multiple Sclerosis

Drug: Methylprednisolone

Drug: Ocrelizumab

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS) (MUSETTE)

This is a randomized, double-blind, controlled, parallel group, multicenter study to evaluate efficacy, safety and PK of a higher dose of ocrelizumab...

Active, not recruiting

Multiple Sclerosis

Drug: Ocrelizumab

Drug: Antihistamine

Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19 (NOVATION-1)

This study is a randomized, double-blind, multicenter, placebo-controlled trial to evaluate the safety and efficacy of a novel therapeutic agent, Nov...

Enrolling

Covid19

Biological: Placebo

Biological: Novaferon